Omontys Side Effects

Serious side effects of Omontys

heart attack or stroke
chest pain spreading to the arm or shoulder, feeling nauseous, upset stomach, and increased sweating
unexplained and strong headache, feeling confused and having trouble seeing, speaking or balancing
coughing up blood, fast breathing, and persistent coughing
feeling weak on one side of the body
swelling and aching of the legs or one leg
pale skin, chills, and numb feeling
rapid weight gain and swelling of the body
shortness of breath or trouble breathing
signs of high potassium such as a slowed heart rate, loss of strength and tingly sensations in the body
blood clotting in the veins
dangerous changes in blood pressure
easy bruising or bleeding such as nose bleeds or bleeding from the nose, mouth, vagina or anus
seizures (convulsions)
faintness or passing out
high fever
swelling of the lips, mouth, throat, tongue or face, trouble breathing and hives or a rash which signify a serious allergic reaction

Common Side Effects of Omontys

diarrhea
coughing or mild fever
upset stomach or throwing up
irritation, redness or swelling at the site of the injection
pain or aching of the back, legs, or arms
joint cramping or pain

Warnings & Recalls for Omontys

Omontys Black Box Warning

Patients who take ESA medications, such as Omontys, face an increased risk for serious cardiovascular complications, such as heart attack, blood clots, and stroke. These conditions may be fatal, and patients should take the lowest, effective dosage of Omontys to avoid developing any of these serious illnesses.

Omontys and Pregnancy

Omontys has been assigned as a FDA pregnancy Category C medicine. Sufficient examinations have not been conducted to know if Omontys could harm the fetus if taken by a pregnant woman. It is unknown if Omontys can be transferred through breast-milk and harm a nursing baby. Before receiving Omontys, let your doctor know if you are pregnant, may become pregnant, or are breastfeeding.

General Warnings

Omontys should not be used by patients who have uncontrolled high blood pressure or are allergic to any ingredient in Omontys. Before receiving Omontys, tell your doctor about any of the following conditions:

heart problems, disease or failure
high blood pressure
if you have ever had a heart attack, stroke or any blood clotting disorder
any blood diseases or disorders
if you have cancer
if you are epileptic or a seizure-causing disorder

Let your healthcare provider know about all medicines and products you are using. Your doctor may require you to take a different dosage. If you are undergoing surgery, be sure to tell the surgeon in advance that you are taking Omontys. Have your blood checked often while using Omontys to be sure that the treatment is working safely and effectively.

Omontys Treatment and Use

Omontys | peginesatide is an erythropoiesis-stimulating agent (ESA) injection marketed by Affymax and Takeda Pharmaceuticals for treating low red blood cell amounts or anemia related to chronic kidney disease. Omontys is prescribed to patients over the age of 18 who are on dialysis.

How Does Omontys Work?

Omontys works by interacting with the bone marrow and increasing the production of red blood cells. This lowers the need for patients with anemia caused by chronic kidney disease to have blood transfusions.

How is Omontys Given?

Omontys is an injection which is administered intravenously (IV). Treatment usually is given with Omontys once each month by a doctor or nurse. If you have been asked to self-administer the injection, be sure to follow all packaged instructions and any advice given to you by your doctor. Dose varies in accordance to the patient’s medical condition, age, and weight.

Patients who are receiving Omontys should have their blood checked on a regular basis.

Other Names for Omontys

Brand name:

Omontys

Generic name:

peginesatide